(CIX: WRAL30)  1,170.48    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: Apple)  118.30    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: QUINTILES)  67.99    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(OP: BASF SE)  82.48    (0 %)  Updated: 05:20 PM EST, Nov 30 2015
(NQ: BioCryst)  10.61    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: BioDelivery)  6.13    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: CEMP)  31.91    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: Cisco)  27.25    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: Cree)  27.64    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: DARA)  0.95    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: EMC)  25.34    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NQ: Extreme Networks)  4.42    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: Facebook)  104.24    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: GLAXOSMITHKLINE)  40.51    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NQ: Alphabet)  742.60    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: IBM)  139.42    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NY: LH)  121.54    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(OP: Lenovo Group)  21.50    (0 %)  Updated: 05:20 PM EST, Nov 30 2015
(NY: MRK)  53.01    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NQ: Microsoft)  54.35    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: NetApp)  30.66    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: NOVARTIS AG)  85.24    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(OP: Novozymes A/S)  48.14    (0 %)  Updated: 05:20 PM EST, Nov 30 2015
(NY: Pfizer)  32.77    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NQ: Pozen)  7.59    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NY: Red Hat)  81.41    (0 %)  Updated: 06:40 PM EST, Nov 30 2015
(NQ: BBRY)  7.94    (0 %)  Updated: 08:10 PM EST, Nov 30 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  12.91    (0 %)  Updated: 08:10 PM EST, Nov 30 2015

Posts tagged “Genomics”

November 9

Duke researchers at Durham Innovation District achieve breakthrough in understanding heart disease

A Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease. The team operates out of the Durham Innovation District.

Tags: Duke, Genomics
October 27

Premium Lock SynShark making valuable shark oil in tobacco plants

SynShark making shark oil in tobacco plants. Every year an estimated 3 to 5 million sharks are slaughtered for a precious omega-2 oil in their livers called squalene, a clear liquid, lighter than water, that helps them float. SynShark, which has operations in NC, wants to harvest squalene from the leaves of tobacco plants that have been genetically engineered to synthesize the oil.

Updated July 14

Premium Lock Durham company's rare disease treatment gives sufferers hope

Bret Kopelan's daughter Rafaella, now eight, was born without skin on her feet and had to have emergency care when her skin began to blister. She suffers from a rare disease that had no effective treatments currently because it doesn't affect enough people to make it commercially viable for most drug companies. So Kopelan is hopeful that a Durham company's treatment gets to market quickly and helps his daughter.

Rafaella Kopelan, who suffers from rare "butterfly children" disease Rafaella Kopelan, who suffers from rare "butterfly children" disease

Updated July 6

Premium Lock AgBiome, Genective team, Southwire buying NC facility, BioDelivery shelves stock

Bulldog In today's Bulldog update of tech stories: BioDelivery Sciences International shelves shares; AgBiome, Genective ink partnership; Southwire buying Huntersville facility.

Updated May 29

Premium Lock Sequenom expanding Morrisville lab

 Sequenom A genetic testing laboratory recruited to the state in 2011 with help from the North Carolina Biotechnology Center is about to expand. The Sequenom Center for Molecular Medicine, a $19 million Morrisville laboratory opened in 2012, will be taking over operations of a sister lab that the company is closing in Grand Rapids, Michigan.

March 31

Premium Lock So why did Quintiles form a joint venture to take on LabCorp?

DNA      Quintiles, the world's largest life science services company, is going to get even bigger - but through a joint venture rather than an acquisition. The deal announced Tuesday to partner with Quest to take on No. 1 lab tester LabCorp is seen as the best way for Quintiles to capitalize on a changing market, a Q executive explains.

March 12

Premium Lock Decoding your genome could extend your life

Human Longevity Inc. Some of the technologies and methods researchers say will allow humans to live far beyond today's life expectancies might seem a bit sci-fi, but last week's CED Life Science Conference presentation by a California scientist behind national headline-grabbing Human Longevity Inc. considers the equally radical inventions of the last 150 years.

March 4

Premium Lock Red Hat's 'cloud' practice; AT&T, Cisco link cars; Uber's buy; AT&T's mobile health move; Sony VR headsets coming

Bulldog In today's Bulldog wrapup of technology and life science news: Red Hat launches a "cloud" practice offering services and technology; AT&T and Cisco team up to connect vehicles; Uber buys a mapping firm; AT&T moves into mobile connected health; and Sony to launch virtual reality headsets next year.

March 3

Premium Lock Ikea 'smart' furniture; Aerie's loss; EU modified crop crackdown; $11.8B chip deal; new jet tracking tech

Bulldog In today's Bulldog wrapup of technology and life science news: Ikea launches "smart" furniture; Aerie Pharmaceuticals reports a loss; EU gives members power to crack down on genetically modified crops; Freescale Semiconductor is sold for $11.8 billion; and new technology will track jetliners.

February 20

Premium Lock DNA breakthrough: FDA approves 23andMe, other tests

DNA      Federal health officials are easing access to DNA tests used to screen parents for devastating genetic disorders that can be passed on to their children. The surprise announcement Thursday offers a path forward for Google-backed genetic testing firm 23andMe, which previously clashed with regulators over its direct-to-consumer technology.

November 21, 2014

Premium Lock Summit showcase: NCSU reaping big harvest in agbio research

Agbio Agriculture research at N.C. State highlights the AgBio Summit with developments spanning robots and drones to honey bees and fish. WRAL TechWire's Allan Maurer reports exclusively for our Insiders.

Updated November 19, 2014

Premium Lock Population bomb: 'The mother of all wicked problems'

Feeding a world population the United Nations estimates will hit 9 billion by 2050 is only one of the social problems caused by an increasing number of people, the director of of the US Department of Agriculture's National Institute of Food and Agriculture tells the AgBio Summit in Raleigh. WRAL TechWire's Allan Maurer reports the details for our Insiders.

Talking population problems at AgBio Summit Talking population problems at AgBio Summit

Updated November 18, 2014

Premium Lock Syngenta faces dozens of lawsuits over genetically modified seed

Agrochemicals giant Syngenta is facing a growing number of lawsuits challenging its release of a genetically modified corn seed that China had not approved for import, with losses to farmers estimated to be at least $1 billion.

Growing corn at Syngenta's new lab Growing corn at Syngenta's new lab

November 18, 2014

Premium Lock Just call North Carolina 'the Mecca, the hub for agbio'

Agbio As NC State prepares to host the AGBIO Summit, the dean of the university's College of Agriculture and Life Sciences says the event will help showcase North Carolina as the "Mecca, the hub for agio." The theme of the event: Feeding a world of 9 billion people in 2050. And action is required, reports WRAL TechWire's Allan Maurer.

Updated August 15, 2014

Premium Lock Ebola outbreak brings global attention to tobacco plant-based drugs

It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. And one of the emerging players is Medicago, which operates a production facility in RTP.

How Medicago process works How Medicago process works

August 12, 2014

Premium Lock Pfizer, 23andMe team up for genetic study of bowel disease

DNA      Pfizer is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.

Updated July 14, 2014

Premium Lock N.C. Research Campus internship program plants seeds to grow STEM careers

The future of food research is taking root in some very fertile ground - the minds of students working on the N.C. Research Campus. In an Insider exclusive for WRAL TechWire, read how a new internship program encourages STEM careers

Michael Balloskis, left, and Brooklyn Phillips in the P2EP program. Michael Balloskis, left, and Brooklyn Phillips in the P2EP program.

Updated June 24, 2014

Premium Lock New Jersey firm buying Gentris for $4.75M; founder to return

Morrisville-based Gentris, which provides storage and testing services to research laboratories, has received a $4.75 million buy-out offer from New Jersey-based Cancer Genetics,

Gentris Gentris

May 13, 2014

Premium Lock GSK to utilize genomics data, services from Metabolon

Triangle-based Metabolon, which recently struck a deal with DNA pioneer Craig Venter to help us find ways to live longer, has another high-profile partner: GlaxoSmithKline. The two neighbors disclosed a new collaboration agreement Tuesday.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

April 2, 2014

Premium Lock Drug giant Baxter acquires Chapel Hill firm for $70M

Heart research Baxter International is acquiring Chapel Hill-based Chatham Therapeutics to gain control of gene-based therapy technology focused on hemophilia. The deal includes a $70 million upfront payment. Additional payments could be made based on development, regulatory and commercial milestones.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith